Researchers at Queen Mary University of London, together with NHS and industry partners, have secured approximately £2 million from UK Research and Innovation (UKRI) through the EPSRC Healthcare Technology Translation Partnership programme to develop a wearable monitoring technology for patients under dialysis treatment.

The four-year project aims to improve early detection of dialysis related complications, a major cause of hospital admissions and treatment disruption. The wearable device is designed to support monitoring at home, helping clinicians identify potential problems earlier and improve patient care.

The project is led by Professor Lei Su from the School of Engineering and Materials Science at Queen Mary, with clinical co-leads Mr Ben Lindsey from Barts Health NHS Trust, and Dr Matt Bartlett from the Royal Free Hospital.

The research builds on previous work by the Queen Mary team in wearable healthcare technologies. The project will include patient co-design activities, volunteer studies, and early-stage clinical testing, with dialysis patients and carers helping to shape device usability and accessibility throughout the programme.

Beyond dialysis care, the researchers believe the technology could support wider healthcare applications, including remote patient monitoring and long-term management of chronic conditions.

The team hopes the project will lay the foundation for larger clinical studies and future deployment within the NHS and beyond.